- Fellowship - Brigham and Women's Hospital (2011-2012), Cardiology
- Fellowship - Brigham and Women's Hospital (2010-2011), Interventional Cardiology
- Fellowship - Cleveland Clinic Foundation (2007-2010), Cardiovascular Disease
- Residency - University of Pennsylvania Health System (2004-2007), Internal Medicine
- Undergraduate School - Harvard School of Public Health (2002-2003), Epidemiology
- Medical School - University of Mumbai (1996-2002)
Dharam Kumbhani, M.D.
- Internal Medicine - Cardiology
- Heart Valve Disorders
- Percutaneous Coronary Interventions (PCI)
Dharam Kumbhani, M.D., is the Section Chief/Director of Interventional Cardiology and an Associate Professor of Medicine in UT Southwestern Medical Center’s Department of Internal Medicine. He is also the Director of the Cardiac Catheterization Laboratory at Clements University Hospital. He specializes in interventional cardiology.
Dr. Kumbhani earned his medical degree with honors at the University of Mumbai. He earned a master’s degree in clinical epidemiology at Harvard University before completing an internship and residency in internal medicine at the Hospital of the University of Pennsylvania and cardiovascular training at the Cleveland Clinic. He then completed fellowships in interventional cardiology and advanced structural and endovascular interventions and a postdoctoral research fellowship at Brigham and Women’s Hospital and Harvard Medical School, where he was also an instructor in cardiology.
He brings a strong background in advanced interventional cardiology techniques to UT Southwestern. His clinical practice specializes in transradial coronary interventions, percutaneous valve technologies, peripheral vascular interventions, and other adult structural heart disease interventions.
Dr. Kumbhani is also internationally recognized in the field of outcomes-based and quality-of-care research. He has authored or co-authored more than 150 articles in medical journals such as the New England Journal of Medicine, Journal of the American Medical Association, Journal of the American College of Cardiology, and Circulation, among others. He has received numerous grants for his research, including from the American Heart Association. He is an elected member of the American College of Epidemiology, the Sigma Xi Research Society, and the U.K.’s Royal College of Physicians.
He is an Associate Editor of Circulation and serves on the Editorial board of Cardiosource for the American College of Cardiology. He served as Co-Chair for the 2017 Expert Consensus Document on Transcatheter Aortic Valve Replacement.
Meet Dr. Kumbhani
Interventional cardiologist Dharam Kumbhani, M.D., doesn’t settle for the traditional treatment options available to patients with complex heart and vascular problems.
A specialist in cutting-edge minimally invasive procedures such as transradial angioplasty to treat coronary artery disease, valve repair for aortic stenosis, and stent-based interventions for patients with peripheral vascular disease, Dr. Kumbhani offers procedures that, while still rare at many U.S. hospitals, promise quicker recovery compared to standard methods.
“We can provide several state-of-the-art treatment options to our patients – especially patients who aren’t good candidates for open-heart surgery – with minimal recovery times,” he says.
For example, he performs transradial angioplasty, which uses a patient’s wrist instead of the groin as the incision point and has a much lower rate of bleeding and faster recovery time.
In addition, he is part of the transcatheter aortic valve replacement (TAVR) team at UT Southwestern Medical Center, which provides aortic valve replacement to patients without open surgery. TAVR offers a new option to many patients who aren’t surgical candidates and may otherwise not receive any treatment.
Dr. Kumbhani also sees patients with various cardiac structural abnormalities or defects, many of which may need a nonsurgical intervention. He cares for patients through his outpatient clinic, which serves patients with heart, valve, and vascular problems.
An epidemiologist as well as a cardiologist, Dr. Kumbhani has conducted wide-ranging research on quality of care and outcomes in patients with various heart and vascular problems. His research focus mirrors his clinical practice: He looks at care of patients with heart attack or chest pain, complex angioplasties, and peripheral vascular disease. He recently published research that was instrumental in highlighting the importance of medications such as statins in preventing repeat procedures and amputations in patients with peripheral vascular disease.
Dr. Kumbhani also offers minimally invasive, stent-based procedures to his peripheral vascular disease (PVD) patients to reduce pain and avoid amputation and invasive bypass surgeries.
“I enjoy my practice,” he says. “Seeing such a wide range of patients and working with a wide range of techniques allows me to stay up to date with the whole heart-care scene, not just a narrow facet of it.”
- American College of Cardiology (2007), Member
- Sigma Xi Research Society (2008), Elected Member
- American Mensa (2008), Elected Member
- American College of Physicians (2008), Member
- American College of Epidemiology (2008), Elected Member
- American Heart Association (2009), Member
- Society for Cardiovascular Angiography and Interventions (2010), Member
- Royal College of Physicians, UK (2012), Elected Member
- Jack B. Wallach Scholarship 2002, Harvard University
- Veterans Affairs Medical Scholar Award 2007, University of Pennsylvania
- Young Investigator Award 2010, American Heart Association
- Tomsich Award for Excellence in Research 2010, Cleveland Clinic
- Gregory Braden Memorial Fellow of the Year Award 2012, Society for Cardiovascular Angiography and Interventions
- First place, Junior Faculty Research 2013, Northwestern Cardiovascular Young Investigators' Forum
- Finalist 2013, Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award, TCT
- ACC/William F. Keating, Esq. Endowment Award 2015, American College of Cardiology
- Leadership Recognition Award 2016, Cardiovascular Research Technologies
- Next Gen Innovator 2017, Cardiology Today
Does volume help predict outcome in surgical disease? in Advances in Surgery
Khuri SF, Hussaini BE, Kumbhani DJ, Healey NA (2005), Philadelphia, Mosby
Optimal long term therapy of the patient after percutaneous coronary intervention in Interventional Cardiology
Kumbhani DJ (2011), New York, Oxford University Press
Landmark trials in interventional cardiology in Cardiovascular clinical trials: putting the evidence into practice
Kumbhani DJ, Bhatt DL (2013 in press), New Jersey, Wiley-Blackwell
Percutaneous coronary intervention in unstable angina/NSTEMI in Clinical Decision Support: Cardiology
Kumbhani DJ (2013 in press), Decision Support in Medicine, LLC
Indication and technique of percutanerous coronary interventions
Bavry AA, Kumbhani DJ (2012), London, Springer Healthcare Ltd.
- Does volume help predict outcome in surgical disease? in Advances in Surgery
Patients with diabetes mellitus undergoing cardiac surgery are at greater risk for developing intraoperative myocardial acidosis.
Kumbhani DJ, Healey NA, Thatte HS, Nawas S, Crittenden MD, Birjiniuk V, Treanor PR, Khuri SF The Journal of thoracic and cardiovascular surgery 2007 Jun 133 6 1566-72
Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes.
Kumbhani DJ, Cannon CP, Fonarow GC, Liang L, Askari AT, Peacock WF, Peterson ED, Bhatt DL JAMA : the journal of the American Medical Association 2009 Nov 302 20 2207-13
Statin therapy and risk of developing type 2 diabetes: a meta-analysis.
Rajpathak SN, Kumbhani DJ, Crandall J, Barzilai N, Alderman M, Ridker PM Diabetes care 2009 Oct 32 10 1924-9
Secondary prevention of stroke: can we do better than aspirin?
Kumbhani DJ, Bhatt DL Lancet neurology 2010 Oct 9 10 942-3
Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: a meta-analysis of randomized controlled trials.
Kumbhani DJ, Bavry AA, Harvey JE, de Souza R, Scarpioni R, Bhatt DL, Kapadia SR American heart journal 2011 Mar 161 3 622-630.e1
Predictors of Adherence to Performance Measures in Patients with Acute Myocardial Infarction.
Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Pan W, Schwamm LH, Bhatt DL The American journal of medicine 2012 Aug
Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
Agarwal S, Bajaj NS, Kumbhani DJ, Tuzcu EM, Kapadia SR JACC. Cardiovascular interventions 2012 Jul 5 7 777-89
Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis.
Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL European heart journal 2012 Nov
Novel strategies for the diagnosis and treatment of arterial access perforations.
Kumbhani DJ, Brilakis ES Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2012 Nov 80 6 1033-4
Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.
Bavry AA, Kumbhani DJ, Gong Y, Handberg EM, Cooper-Dehoff RM, Pepine CJ Journal of the American Heart Association 2013 2 4 e000205
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.
Kumbhani DJ, Wells BJ, Lincoff AM, Jain A, Arrigain S, Yu C, Goormastic M, Ellis SG, Blackstone E, Kattan MW American journal of cardiovascular disease 2013 3 1 39-52
Same-Day Discharge After Percutaneous Coronary Intervention: A Meta-Analysis.
Brayton KM, Patel VG, Stave C, de Lemos JA, Kumbhani DJ Journal of the American College of Cardiology 2013 Apr
Lessons from the heart: Troponin elevations in patients with established peripheral artery disease.
de Lemos JA, Kumbhani DJ Journal of the American College of Cardiology 2013 Jun
Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients With Atherosclerosis.
Kumbhani DJ, Gabriel Steg P, Cannon CP, Eagle KA, Smith SC, Hoffman E, Goto S, Magnus Ohman E, Bhatt DL The American journal of medicine 2013 Jun
Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: An updated meta-analysis of randomized trials.
Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL Journal of the American College of Cardiology 2013 May
New Oral Anticoagulants and the Risk of Intracranial Hemorrhage: Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation.
Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ JAMA neurology 2013 Oct
- Patients with diabetes mellitus undergoing cardiac surgery are at greater risk for developing intraoperative myocardial acidosis.
- Clinical trials
- Cardiovascular outcomes research
- Valvular heart disease
- Vascular medicine
- Application of large national databases to understand disparities in health care delivery
- Heart Valve Disorders
- Percutaneous Coronary Interventions (PCI)
- Diagnostic Cardiac Catheterization
- Heart Valve Repair/Replacement
- General Cardiology
Q&A by Dr. Kumbhani
AHA Scientific Sessions: Dr. Dharam Kumbhani
Darham Kumbhani, M.D., interventional cardiologist at UT Southwestern Medical Center, shares an update on TAVR at the 2017 American Heart Association Scientific Sessions.